Changes in IL-16 Expression in the Ovary during Aging and Its Potential Consequences to Ovarian Pathology

Jessica Ramirez,Pincas Bitterman,Sanjib Basu,Animesh Barua
DOI: https://doi.org/10.1155/2022/2870389
IF: 4.4929
2022-04-26
Journal of Immunology Research
Abstract:Aging in females is not only associated with the changes in hormonal status but is also responsible for dysregulation of immune functions in various organs including ovaries. The goal of this study was to determine whether the expression of interleukin 16 (IL-16), a proinflammatory and chemoattractant cytokine, changes during ovarian aging, to determine factors involved in such changes in IL-16 expression, and to examine if changes in IL-16 expression during aging predisposes the ovary to pathologies. Ovarian tissues from premenopausal women (30-50 years old), women at early menopause (55-59 years old), and late menopause (60-85 years old) were used. In addition, tumor tissues from patients with ovarian high-grade serous carcinoma at early stage ( n = 5 ) were also used as reference tissue for comparing the expression of several selected markers in aging ovaries. The expression of IL-16, frequency of macrophages (a source of IL-16) and expression of microRNA (miR) 125a-5p (a regulator of IL-16 gene) were performed by immunohistochemistry, immunoblotting, and gene expression assays. In addition, we examined changes in nuclear expression of IL-16 expression with regards to exposure to follicle-stimulating hormone (FSH) by in vitro cell culture assays with human ovarian cancer cells. The frequencies of IL-16 expressing cells were significantly higher in ovarian stroma in women at early and late menopause as compared with premenopausal women ( P < 0.0001 ). Similar patterns were also observed for macrophages. Expression of miR-125a-5p decreased significantly ( P < 0.001 ) with the increase in IL-16 expression during aging. Furthermore, expression of nuclear IL-16 increased remarkably upon exposure to FSH. Consequently, ovarian aging is associated with increased expression of IL-16 including its nuclear fraction. Therefore, persistent high levels of FSH in postmenopausal women may be a factor for enhanced expression of IL-16. Effects of increased nuclear fraction of IL-16 need to be examined.
immunology
What problem does this paper attempt to address?
The problems that this paper attempts to solve are: to determine the expression changes of interleukin - 16 (IL - 16) during ovarian aging, explore the factors related to this change, and study whether the change in IL - 16 expression makes the ovary more prone to pathological changes. Specifically, the researchers hope to understand the following points: 1. **Changes in IL - 16 expression**: Does the expression of IL - 16 change as the ovary ages? 2. **Factors affecting IL - 16 expression**: Which factors will affect the changes in IL - 16 expression? 3. **Potential consequences of changes in IL - 16 expression**: Will the changes in IL - 16 expression increase the risk of ovarian pathological conditions? To answer these questions, the researchers used ovarian tissue samples from women of different age groups (including women aged 30 - 50, 55 - 59 and 60 - 85), and tumor tissues from patients with early - stage high - grade serous ovarian cancer as references. Through immunohistochemistry, immunoblotting and gene expression analysis and other methods, the researchers evaluated the expression level of IL - 16, the frequency of macrophages (as a source of IL - 16) and the expression of miR - 125a - 5p (a regulator of the IL - 16 gene). In addition, in vitro cell culture experiments were also carried out to study the effect of FSH exposure on the nuclear expression of IL - 16 in human ovarian cancer cells. ### Main findings of the study: - **IL - 16 expression increases with age**: In the ovarian stroma of pre - menopausal and post - menopausal women, the expression of IL - 16 is significantly higher than that in women of childbearing age. - **miR - 125a - 5p expression decreases**: As the expression of IL - 16 increases, the expression of miR - 125a - 5p decreases significantly. - **FSH exposure increases IL - 16 nuclear expression**: In vitro experiments show that FSH exposure can significantly increase the nuclear expression of IL - 16. - **Pathological correlation**: Persistently high levels of FSH may be related to the enhanced expression of IL - 16 in post - menopausal women, which may in turn increase the risk of ovarian pathological conditions. In conclusion, this study reveals the mechanism of the expression change of IL - 16 during ovarian aging and its potential pathological significance, providing important information for preventing chronic abnormalities in post - menopausal women.